|
|
||||||||
Radiology, Vol 191, 371-377, Copyright © 1994 by Radiological Society of North America
ARTICLES |
RL Wahl, LE Quint, RL Greenough, CR Meyer, RI White and MB Orringer
Department of Internal Medicine (Division of Nuclear Medicine), University of Michigan Medical Center, Ann Arbor 48109-0028.
PURPOSE: To evaluate use of positron emission tomography (PET) with 2- [fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) in detection of mediastinal lymph node metastases from non-small cell lung cancer. MATERIALS AND METHODS: A prospective trial to compare FDG PET and computed tomography (CT) of the thorax was performed in 23 patients with newly diagnosed or suspected non-small cell lung cancer. Blinded interpretations of CT alone, PET alone, CT and PET together, and fusion images were performed, and the results were compared with pathologic results. RESULTS: Nineteen of 23 patients had non-small cell lung cancer. Prevalence of mediastinal involvement was 41%. In staging disease in the mediastinum, CT alone was 64% sensitive, 44% specific, and 52% accurate, whereas PET alone and fusion images were 82% sensitive, 81% specific, and 81% accurate (P < .05). CONCLUSIONS: FDG PET was more accurate than CT in staging disease in the mediastinum in patients with lung cancer and appears to be the preferred imaging method in this clinical setting.
This article has been cited by other articles:
![]() |
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta 18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review J Natl Cancer Inst, December 5, 2007; 99(23): 1753 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.M. Piet, F. J. Lagerwaard, P. W.A. Kunst, J. R. van Sornsen de Koste, B. J. Slotman, and S. Senan Can Mediastinal Nodal Mobility Explain the Low Yield Rates for Transbronchial Needle Aspiration Without Real-Time Imaging? Chest, June 1, 2007; 131(6): 1783 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomimaru, M. Higashiyama, J. Okami, K. Oda, K. Takami, K. Kodama, and Y. Tsukamoto Surgical Results of Lung Cancer with Sarcoid Reaction in Regional Lymph Nodes Jpn. J. Clin. Oncol., February 1, 2007; 37(2): 90 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shiraishi, S. Tomiguchi, D. Utsunomiya, K. Kawanaka, K. Awai, S. Morishita, T. Okuda, K. Yokotsuka, and Y. Yamashita Quantitative Analysis and Effect of Attenuation Correction on Lymph Node Staging of Non-Small Cell Lung Cancer on SPECT and CT. Am. J. Roentgenol., May 1, 2006; 186(5): 1450 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Chen and F. Dehdashti Advances in Positron Emission Tomographic Imaging of Lung Cancer Proceedings of the ATS, December 1, 2005; 2(6): 541 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart Imaging of the Patient with Non-Small Cell Lung Cancer Radiology, December 1, 2005; 237(3): 803 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shekhar, V. Walimbe, S. Raja, V. Zagrodsky, M. Kanvinde, G. Wu, and B. Bybel Automated 3-Dimensional Elastic Registration of Whole-Body PET and CT from Separate or Combined Scanners J. Nucl. Med., September 1, 2005; 46(9): 1488 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shim, K. S. Lee, B.-T. Kim, M. J. Chung, E. J. Lee, J. Han, J. Y. Choi, O J. Kwon, Y. M. Shim, and S. Kim Non-Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging Radiology, September 1, 2005; 236(3): 1011 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Birim, A. P. Kappetein, T. Stijnen, and A. J.J.C. Bogers Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer Ann. Thorac. Surg., January 1, 2005; 79(1): 375 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Viney, M. J. Boyer, M. T. King, P. M. Kenny, C. A. Pollicino, J. M. McLean, B. C. McCaughan, and M. J. Fulham Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer J. Clin. Oncol., June 15, 2004; 22(12): 2357 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohno, H. Hatabu, D. Takenaka, T. Higashino, H. Watanabe, C. Ohbayashi, M. Yoshimura, M. Satouchi, Y. Nishimura, and K. Sugimura Metastases in Mediastinal and Hilar Lymph Nodes in Patients with Non-Small Cell Lung Cancer: Quantitative and Qualitative Assessment with STIR Turbo Spin-Echo MR Imaging Radiology, June 1, 2004; 231(3): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Halter, A. K. Buck, H. Schirrmeister, I. Wurziger, F. Liewald, G. Glatting, B. Neumaier, L. Sunder-Plassmann, S. N. Reske, and M. Hetzel [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: Alternative or diagnostic adjunct to 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions? J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1093 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Duysinx, D. Nguyen, R. Louis, D. Cataldo, T. Belhocine, P. Bartsch, and T. Bury Evaluation of Pleural Disease With 18-Fluorodeoxyglucose Positron Emission Tomography Imaging Chest, February 1, 2004; 125(2): 489 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kahn, Y. Menda, K. Kernstine, D. Bushnell, K. McLaughlin, S. Miller, and K. Berbaum The Utility of 99mTc Depreotide Compared With F-18 Fluorodeoxyglucose Positron Emission Tomography and Surgical Staging in Patients With Suspected Non-small Cell Lung Cancer Chest, February 1, 2004; 125(2): 494 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wahl Why Nearly All PET of Abdominal and Pelvic Cancers Will Be Performed as PET/CT J. Nucl. Med., January 1, 2004; 45(90010): 82S - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Bradley, C. A. Perez, F. Dehdashti, and B. A. Siegel Implementing Biologic Target Volumes in Radiation Treatment Planning for Non-Small Cell Lung Cancer J. Nucl. Med., January 1, 2004; 45(90010): 96S - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gould, W. G. Kuschner, C. E. Rydzak, C. C. Maclean, A. N. Demas, H. Shigemitsu, J. K. Chan, and D. K. Owens Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis Ann Intern Med, December 2, 2003; 139(11): 879 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bar-Shalom, N. Yefremov, L. Guralnik, D. Gaitini, A. Frenkel, A. Kuten, H. Altman, Z. Keidar, and O. Israel Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient Management J. Nucl. Med., August 1, 2003; 44(8): 1200 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Schillaci, A. Spanu, F. Scopinaro, F. Monteleone, M. E. Solinas, P. Volpino, P. Pirina, P. Marongiu, V. Cangemi, and G. Madeddu Mediastinal Lymph Node Involvement in Non-Small Cell Lung Cancer: Evaluation with 99mTc-Tetrofosmin SPECT and Comparison with CT J. Nucl. Med., August 1, 2003; 44(8): 1219 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lardinois, W. Weder, T. F. Hany, E. M. Kamel, S. Korom, B. Seifert, G. K. von Schulthess, and H. C. Steinert Staging of Non-Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography N. Engl. J. Med., June 19, 2003; 348(25): 2500 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. LeBlanc, R. Espada, and G. Ergun Non-small Cell Lung Cancer Staging Techniques and Endoscopic Ultrasound: Tissue Is Still the Issue Chest, May 1, 2003; 123(5): 1718 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Ryu, M.-H. Kim, S.-C. Choi, C.-W. Choi, and K.-H. Lee Detection of Early Recurrence with 18F-FDG PET in Patients with Cervical Cancer J. Nucl. Med., March 1, 2003; 44(3): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hicks and M. P. Mac Manus 18F-FDG PET in Candidates for Radiation Therapy: Is It Important and How Do We Validate Its Impact? J. Nucl. Med., January 1, 2003; 44(1): 30 - 32. [Full Text] [PDF] |
||||
![]() |
E. M. Toloza, L. Harpole, and D. C. McCrory Noninvasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence Chest, January 1, 2003; 123(1_suppl): 137S - 146S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Hany, H. C. Steinert, G. W. Goerres, A. Buck, and G. K. von Schulthess PET Diagnostic Accuracy: Improvement with In-Line PET-CT System: Initial Results Radiology, November 1, 2002; 225(2): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Israel, M. Mor, D. Gaitini, Z. Keidar, L. Guralnik, A. Engel, A. Frenkel, R. Bar-Shalom, and A. Kuten Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/CT System Using 18F-FDG J. Nucl. Med., September 1, 2002; 43(9): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trojan, M. Jermann, C. Taverna, and T. F. Hany Fusion PET-CT imaging of neurolymphomatosis Ann. Onc., May 1, 2002; 13(5): 802 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Aquino, J. C. Asmuth, R. H. Moore, S. B. Weise, and A. J. Fischman Improved Image Interpretation with Registered Thoracic CT and Positron Emission Tomography Data Sets Am. J. Roentgenol., April 1, 2002; 178(4): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Nabi and J. M. Zubeldia Clinical Applications of 18F-FDG in Oncology J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
A G Pitman, R J Hicks, D S Binns, R E Ware, V Kalff, A F McKenzie, D L Ball, and M P MacManus Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses Br. J. Radiol., February 1, 2002; 75(890): 114 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rydzewski, F. Dehdashti, B. A. Gordon, S. A. Teefey, S. M. Strasberg, and B. A. Siegel Usefulness of Intraoperative Sonography for Revealing Hepatic Metastases from Colorectal Cancer in Patients Selected for Surgery After Undergoing FDG PET Am. J. Roentgenol., February 1, 2002; 178(2): 353 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Verschakelen, J. Bogaert, and W. De Wever Computed tomography in staging for lung cancer Eur. Respir. J., February 1, 2002; 19(35_suppl): 40S - 48s. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. Vansteenkiste Imaging in lung cancer: positron emission tomography scan Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akhurst, R. J. Downey, M. S. Ginsberg, M. Gonen, M. Bains, R. Korst, R. J. Ginsberg, V. W. Rusch, and S. M. Larson An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Ann. Thorac. Surg., January 1, 2002; 73(1): 259 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Groell, M. Wiltgen, G. Wolf, and W. Habermann Digital Image Fusion of Early and Delayed CT Scans: How to Achieve Optimal Opacification of Vessels and Squamous Cell Carcinomas of the Head and Neck Am. J. Roentgenol., January 1, 2002; 178(1): 211 - 213. [Full Text] [PDF] |
||||
![]() |
G Laking and P Price 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer Thorax, September 1, 2001; 56(90002): ii38 - 44. [Full Text] [PDF] |
||||
![]() |
W. B. Eubank, D. A. Mankoff, J. Takasugi, H. Vesselle, J. F. Eary, T. J. Shanley, J. R. Gralow, A. Charlop, G. K. Ellis, K. L. Lindsley, et al. 18Fluorodeoxyglucose Positron Emission Tomography to Detect Mediastinal or Internal Mammary Metastases in Breast Cancer J. Clin. Oncol., August 1, 2001; 19(15): 3516 - 3523. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF] |
||||
![]() |
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis JAMA, February 21, 2001; 285(7): 914 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-U. Hung, Y.-C. Shiau, S.-C. Tsai, Y.-J. Ho, C.-H. Kao, and R.-F. Yen Differentiation of Radiographically Indeterminate Solitary Pulmonary Nodules with [18F]Fluoro-2-deoxyglucose Positron Emission Tomography Jpn. J. Clin. Oncol., February 1, 2001; 31(2): 51 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kalff, R. J. Hicks, M. P. MacManus, D. S. Binns, A. F. McKenzie, R. E. Ware, A. Hogg, and D. L. Ball Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non-Small-Cell Lung Cancer: A Prospective Study J. Clin. Oncol., January 1, 2001; 19(1): 111 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, S. J. Park, B.-T. Kim, K. S. Lee, and Y. M. Shim Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography Ann. Thorac. Surg., January 1, 2001; 71(1): 290 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. White, E. A. Weiner, P. Patel, and E. J. Britt Transbronchial Needle Aspiration : Guidance With CT Fluoroscopy Chest, December 1, 2000; 118(6): 1630 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Higashi, S. J. Fisher, R. S. Brown, K. Nakada, G. L. Walter, and R. L. Wahl Evaluation of the Early Effect of Local Irradiation on Normal Rodent Bone Marrow Metabolism Using FDG: Preclinical PET Studies J. Nucl. Med., December 1, 2000; 41(12): 2026 - 2035. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dhital, C. A.B. Saunders, P. T. Seed, M. J. O'Doherty, and J. Dussek [18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 425 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pieterman, J. W.G. van Putten, J. J. Meuzelaar, E. L. Mooyaart, W. Vaalburg, G. H. Koeter, V. Fidler, J. Pruim, and H. J.M. Groen Preoperative Staging of Non-Small-Cell Lung Cancer with Positron-Emission Tomography N. Engl. J. Med., July 27, 2000; 343(4): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. Berlangieri and A. M. Scott Metabolic Staging of Lung Cancer N. Engl. J. Med., July 27, 2000; 343(4): 290 - 292. [Full Text] |
||||
![]() |
M. A. Farrell, H. P. McAdams, J. E. Herndon, and E. F. Patz Jr Non-Small Cell Lung Cancer: FDG PET for Nodal Staging in Patients with Stage I Disease Radiology, June 1, 2000; 215(3): 886 - 890. [Abstract] [Full Text] |
||||
![]() |
E. F. Patz Jr Imaging Bronchogenic Carcinoma Chest, April 1, 2000; 117(4_suppl_1): 90S - 95S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Gupta, G. M. Graeber, and H. A. Bishop Comparative Efficacy of Positron Emission Tomography With Fluorodeoxyglucose in Evaluation of Small (<1 cm), Intermediate (1 to 3 cm), and Large (>3 cm) Lymph Node Lesions Chest, March 1, 2000; 117(3): 773 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kosuda, K. Ichihara, M. Watanabe, H. Kobayashi, and S. Kusano Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan Chest, February 1, 2000; 117(2): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Dwamena, S. S. Sonnad, J. O. Angobaldo, and R. L. Wahl Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s-Meta-analytic Comparison Of PET and CT Radiology, November 1, 1999; 213(2): 530 - 536. [Abstract] [Full Text] |
||||
![]() |
K. H. Kernstine, W. Stanford, B. F. Mullan, N. P. Rossi, B. H. Thompson, D. L. Bushnell, K. A. McLaughlin, and J. A. Kern PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma Ann. Thorac. Surg., September 1, 1999; 68(3): 1022 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U Berlangieri, A. M Scott, S. R Knight, G. J Fitt, O. F Hennessy, H. J Tochon-Danguy, C Peter Clarke, and W John McKay F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S25 - S30. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Anzai, S. Minoshima, G. T. Wolf, and R. L. Wahl Head and Neck Cancer: Detection of Recurrence with Three-dimensional Principal Components Analysis at Dynamic FDG PET Radiology, July 1, 1999; 212(1): 285 - 290. [Abstract] [Full Text] |
||||
![]() |
V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text] |
||||
![]() |
V. J. Lowe and K. S. Naunheim Positron Emission Tomography in Lung Cancer Ann. Thorac. Surg., June 1, 1998; 65(6): 1821 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Delbeke, W. H. Martin, M. P. Sandler, W. C. Chapman, J. K. Wright Jr, and C. W. Pinson Evaluation of Benign vs Malignant Hepatic Lesions With Positron Emission Tomography Arch Surg, May 1, 1998; 133(5): 510 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
|